Comparison
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 vs 4 5 Toe Syndactyly C1837836
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Endogenous Maternal Derived Androgen and 4 5 Toe Syndactyly for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
A condition where hormones from the mother cross the placenta and cause atypical development in an XX fetus. It is present at birth. Management involves pediatric specialists and may include hormone therapy.
4 5 Toe Syndactyly C1837836
Fusion of the 4th and 5th toes, present from birth. May affect balance or cause difficulty with footwear. Surgery can separate the toes if needed.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
Variable
4 5 Toe Syndactyly C1837836
0-0
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
severe
4 5 Toe Syndactyly C1837836
mild
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
Chronic
4 5 Toe Syndactyly C1837836
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
No
4 5 Toe Syndactyly C1837836
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
reproductive
4 5 Toe Syndactyly C1837836
musculoskeletal
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
endocrine
4 5 Toe Syndactyly C1837836
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-endogenous-maternal-derived-androgen-C5679875 and 4-5-toe-syndactyly-C1837836 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 | 4 5 Toe Syndactyly C1837836 | Discriminating power |
|---|---|---|---|
| External genital appearance | Atypical genital development may be present at birth in an XX infant. | Genital development is not described as affected. | High |
| Toe anatomy | Toe fusion is not a defining feature in the supplied data. | Fourth and fifth toes are fused from birth. | High |
| Functional concern | Concern centers on sex development and endocrine care. | Concern may involve footwear or balance. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 when
Atypical genital findings in an XX newborn
This matches the described maternal-androgen-related disorder of sex development.
Moderate
Need for pediatric endocrine and DSD evaluation
Management is described as specialist-led and may include hormone therapy.
Moderate
Suspected prenatal androgen exposure
The stated mechanism is maternal hormones crossing the placenta.
Low
Choose 4 5 Toe Syndactyly C1837836 when
Visible fusion limited to the fourth and fifth toes
This is the defining finding supplied for syndactyly.
High
Footwear irritation or mild balance difficulty
These are the functional issues mentioned, without reproductive involvement.
Moderate
Consideration of toe-separation surgery
Surgery is described as optional if clinically needed.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 | 4 5 Toe Syndactyly C1837836 | Interpretation |
|---|---|---|---|
| Physical examination | Focuses on genital phenotype and associated findings. | Shows congenital fusion of the fourth and fifth toes. | Exam findings point to different body systems. |
| Chromosomal or endocrine assessment | May be used by specialists to characterize an XX DSD; exact tests are not specified. | Not indicated by the supplied syndactyly description alone. | Do not treat an abnormal result as a diagnosis without clinician review. |
| Imaging of the foot | No foot-imaging expectation is established. | May clarify soft-tissue or bone involvement if surgery is considered. | Use is clinical, not diagnostic of the DSD. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
- Outcome
- A chronic condition whose individual outcome is not established here.
- Factors
- Phenotype, endocrine findings, and specialist management may influence care needs.
4 5 Toe Syndactyly C1837836
- Outcome
- Generally a mild congenital difference; functional impact varies.
- Factors
- Footwear tolerance, balance, and whether surgery is chosen.
Time frame: Both are present from birth, with variable later course.
No shared prognosis should be inferred from these sparse data.
Complications comparison
| Complication | Presentation |
|---|---|
| Identity and endocrine complexity | May require long-term specialist and psychosocial support. Not a described feature. Specific outcomes are not established here. |
| Footwear or gait difficulty | Not described. May occur because of toe fusion. Severity is characterized as mild. |
| Treatment-related issues | Hormone therapy may be considered, but doses and effects are not specified. Surgical separation may be considered if needed. Decisions require individualized clinician judgment. |
Patient education highlights
- HighDifferent conditions
These findings affect different systems and should not be interpreted as one diagnosis.
- HighSpecialist care
Suspected DSD needs pediatric specialist assessment; syndactyly is usually a mild congenital toe finding.
- MediumUncertain details
Prevalence, laboratory cutoffs, mortality, and exact treatment doses are not established by this comparison.